1. Home
  2. List
Reference Patent

Reference - List

  • 29 Hits
  • Search Condition : Filter (MeSH = Neoplasms / immunology)
Species Resource Title
Mice RBRC05737 Protocol for transcutaneous tumor photolabeling to track immune cells in vivo using Kaede mice.
Human and Animal Cells PK-59(RCB1901) , NCC-StC-K140(RCB2224) A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression.
Human and Animal Cells RAW 264(RCB0535) Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages.
Cord blood stem cells for research NALM-6(RCB1933) Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells.
Human and Animal Cells LM8(RCB1450) TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation.
Human and Animal Cells Colon-26(RCB2657) Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
Human and Animal Cells OS-RC-2(RCB0735) The novel CA IX inhibition antibody chKM4927 shows anti-tumor efficacy in vivo.
Human and Animal Cells Colon-26(RCB2657) , B16/BL6(RCB2638) Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.
Human and Animal Cells KP4(RCB1005) ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence.
Human and Animal Cells NALM-6(RCB1933) , PK45H(RCB1973) , LC-2/ad(RCB0440) Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease.
Human and Animal Cells PANC-1(RCB2095) Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases.
Human and Animal Cells NALM-6(RCB1933) , CCRF-CEM(RCB1980) A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Human and Animal Cells MBT-2(RCB0544) , 293T(RCB2202) Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2).
Human and Animal Cells Colon-26(RCB2657) Tumor growth suppression by the combination of nanobubbles and ultrasound.
Drosophila 1762R-1 Role for phagocytosis in the prevention of neoplastic transformation in Drosophila.
Human and Animal Cells YAC-1 Baculovirus directly activates murine NK cells via TLR9.
Human and Animal Cells HEV0060 , PC-9(RCB4455) Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Human and Animal Cells KP4(RCB1005) , EBC-1(RCB1965) Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.
Human and Animal Cells K562 Establishment of nude mice with complete loss of lymphocytes and NK cells and application for in vivo bio-imaging.
Human and Animal Cells SSP-25(RCB1293) , RBE(RCB1292) , YSCCC(RCB1549) Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.